HENRY E REYES
Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology WILLIAMSVILLE, NY NPI 1144456880
Browse related groups: Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology NY Applied Medical Resources Corporation All categories
General Payments — all program years on this page
$4,526.50
- Category: General Payments
- Program years: PY2019–2024
- Record count: 95
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,679.14 across 33 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000.00 | 1 |
| Food and Beverage | $679.14 | 32 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Applied Medical Resources Corporation | $1,000.00 | 1 |
| EISAI INC. | $132.64 | 3 |
| Janssen Biotech, Inc. | $76.81 | 4 |
| Acerta Pharma LLC | $68.78 | 4 |
| Merck Sharp & Dohme Corporation | $61.06 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $57.21 | 3 |
| GENZYME CORPORATION | $39.26 | 2 |
| Incyte Corporation | $23.09 | 1 |
| Regeneron Healthcare Solutions, Inc. | $22.76 | 1 |
| ADC Therapeutics America, Inc. | $21.66 | 1 |
| GlaxoSmithKline, LLC. | $20.56 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.52 | 1 |
| Genmab U.S., Inc. | $19.06 | 1 |
| Exelixis Inc. | $18.91 | 1 |
| AVEO Pharmaceuticals, Inc. | $18.02 | 1 |
| Tempus AI, Inc | $16.70 | 1 |
| Karyopharm Therapeutics Inc. | $16.53 | 1 |
| Alnylam Pharmaceuticals Inc. | $15.40 | 1 |
| ACCORD HEALTHCARE, INC. | $15.18 | 1 |
| ABBVIE INC. | $14.99 | 1 |
By program year
Records — PY2024 (33)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.